PDL BioPharma Inc (NASDAQ:PDLI)

3.33
Delayed Data
As of Sep 18
 +0.095 / +2.94%
Today’s Change
1.68
Today|||52-Week Range
3.78
+25.87%
Year-to-Date
PDL Bio completes divestiture of the Noden Pharma to Stanley Capital
Sep 09 / Seeking Alpha - Paid Partner Content
PDL BioPharma to buy ~$15M convertible notes in tender offer
Aug 28 / Seeking Alpha - Paid Partner Content
AGTC, FIVE, ZUO and PD among after-hours movers
Sep 02 / Seeking Alpha - Paid Partner Content
PDL BioPharma advancing Lensar spinoff
Aug 26 / Seeking Alpha - Paid Partner Content